Shankar Musunuri
CIK: 0001791820
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Ocugen, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Oct 9, 2026OCGN
Ocugen, Inc.
Sale(S)Direct468.7K shares at avg. $0.95$445K - Oct 9, 2026OCGN
Ocugen, Inc.
Sale(S)Indirect57.3K shares at avg. $0.95$54K - Sep 9, 2026OCGN
Ocugen, Inc.
Sale(S)Direct468.7K shares at avg. $1.12$525K - Sep 9, 2026OCGN
Ocugen, Inc.
Sale(S)Indirect57.3K shares at avg. $1.12$64K - Jan 2, 2026OCGN
Ocugen, Inc.
Award(A)Direct3.1M shares- - Jan 3, 2025OCGN
Ocugen, Inc.
Tax Payment(F)Direct177.1K shares at avg. $0.89$158K - Jan 2, 2025OCGN
Ocugen, Inc.
Award(A)DirectOption (Right to Buy)
1.8M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 9, 2026 | OCGN Ocugen, Inc. | Sale(S) | 468,727 | $0.95 | $445,291 | Direct |
| Oct 9, 2026 | OCGN Ocugen, Inc. | Sale(S) | 57,264 | $0.95 | $54,401 | Indirect |
| Sep 9, 2026 | OCGN Ocugen, Inc. | Sale(S) | 468,727 | $1.12 | $524,974 | Direct |
| Sep 9, 2026 | OCGN Ocugen, Inc. | Sale(S) | 57,264 | $1.12 | $64,136 | Indirect |
| Jan 2, 2026 | OCGN Ocugen, Inc. | Award(A) | 3,123,201 | - | $0 | Direct |
| Jan 3, 2025 | OCGN Ocugen, Inc. | Tax Payment(F) | 177,146 | $0.89 | $158,457 | Direct |
| Jan 2, 2025 | OCGN Ocugen, Inc. | Award(A) Option (Right to Buy) | 1,827,485 | - | - | Direct |
1-7 of 7 transactions
About Musunuri Shankar
Musunuri Shankar (SEC CIK 0001791820) files insider reports with the SEC as Chief Executive Officer of Ocugen, Inc. (OCGN).
Signal8 holds 4 ownership filings by Musunuri Shankar, all Form 4s, filed between Jan 6, 2025 and Oct 13, 2026. Those filings report 7 transactions, from Jan 2, 2025 to Oct 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Musunuri Shankar's filings is in MALVERN, PA.
Recent filings by Musunuri Shankar
- Oct 9, 2026: Open-market sales of OCGN shares (2 lines, Form 4, code S).
- Sep 9, 2026: Open-market sales of OCGN shares (2 lines, Form 4, code S).
- Jan 2, 2026: Grant or award of OCGN shares (Form 4, code A).
- Jan 3, 2025: Tax withholding of OCGN shares (Form 4, code F).
- Jan 2, 2025: Grant or award of OCGN derivative securities (Form 4, code A).
Other insiders filing for Ocugen, Inc. (OCGN)
- Johnson-Greene Treerita Essalima, Chief Financial Officer
- Kompella Uday, Director
- Chandrasekhar Satishchandran, Director
- Castillo Kirsten, Director
- Zhang Junge, Director
- Coleman Blaise, Director